Ormdl sphingolipid biosynthesis regulator 3
Ormdl sphingolipid biosynthesis regulator 3 (ORMDL3) is a protein that in humans is encoded by the ORMDL3 gene. This protein is part of the ORM (ORMDL sphingolipid biosynthesis regulator) family, which plays a significant role in the regulation of sphingolipid metabolism. Sphingolipids are a class of lipids involved in various cellular processes, including cell membrane structure and signaling. The regulation of sphingolipid synthesis is crucial for maintaining cellular homeostasis and function.
Function[edit | edit source]
ORMDL3 is involved in the negative regulation of sphingolipid biosynthesis. It acts by inhibiting serine palmitoyltransferase (SPT), the enzyme responsible for the first step in sphingolipid production. By controlling the activity of SPT, ORMDL3 helps to regulate the concentration of sphingolipids within the cell, thus playing a critical role in cell membrane integrity, signaling pathways, and potentially in the regulation of cell proliferation and apoptosis.
Genetic Association[edit | edit source]
Research has identified a strong association between variations in the ORMDL3 gene and the risk of developing several inflammatory diseases, including asthma, eczema, and Crohn's disease. The ORMDL3 gene is located on chromosome 17q21, a region that has been linked to these conditions through genome-wide association studies (GWAS). The exact mechanism by which ORMDL3 contributes to these diseases is not fully understood, but it is thought to involve the dysregulation of sphingolipid metabolism and its effects on inflammatory pathways.
Clinical Significance[edit | edit source]
Given its association with inflammatory diseases, ORMDL3 is a potential target for therapeutic intervention. Modulating the expression or activity of ORMDL3 could offer new avenues for the treatment of conditions like asthma and Crohn's disease by affecting the underlying sphingolipid metabolism and inflammatory responses. However, further research is needed to fully understand the role of ORMDL3 in disease pathogenesis and to develop effective strategies for targeting this protein in therapy.
See Also[edit | edit source]
 | This biology article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
